Skip to search formSkip to main contentSkip to account menu

Treprostinil

Known as: treprostinil [Chemical/Ingredient], (1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid, Treprostinilo 
National Institutes of Health

Related topics

Related topics

19 relations
12 HR Treprostinil 1 MG Extended Release Oral Tablet [Orenitram]12 HR Treprostinil 2.5 MG Extended Release Oral TabletDecreased Blood Pressure [PE]Hypersensitivity

Broader (2)

Antihypertensive AgentsEpoprostenol

Narrower (5)

RemodulinTyvasoUT-15Uniprost

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Inhaled Treprostinil Drug Delivery During Mechanical Ventilation and Spontaneous Breathing Using Two Different Nebulizers
Objectives: To determine the feasibility of delivering inhaled treprostinil during mechanical ventilation and spontaneous… 
Review
2013
Review
2013
Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
Background Inhaled treprostinil is a prostacyclin analog approved for the treatment of pulmonary arterial hypertension (PAH) that… 
2013
2013
Cathodal Iontophoresis of Treprostinil Induces a Sustained Increase in Cutaneous Blood Flux in Healthy Volunteers
Prostacyclin analogues are the most effective drugs to treat sclerodermic digital ulcers, but their systemic use is limited by… 
2012
2012
Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension.
2012
2012
Has the 6-min walk distance run its course?
2010
2010
Targeting of the prostacyclin specific IP1 receptor in lungs with molecular conjugates comprising prostaglandin I2 analogues.
2010
2010
Epoprostenol-associated pneumonitis: diagnostic use of a T-cell proliferation assay.
2008
2008
The Role of Treprostinil in the Management of Pulmonary Hypertension
Pulmonary arterial hypertension (PAH) is a severely disabling disorder characterized by sustained elevations of pulmonary… 
2007
2007
Treprostinil potentiates the positive inotropic effect of catecholamines in adult rat ventricular cardiomyocytes
Prostanoids have been shown to improve exercise tolerance, hemodynamics and quality of life in patients with pulmonary arterial… 
Review
2006
Review
2006
Pharmacotherapy for Idiopathic Pulmonary Arterial Hypertension During the Past 25 Years
Objective. To review the current pharmacotherapy for idiopathic pulmonary arterial hypertension (IPAH). 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)